CME and CFTC Clash Over On-Chain Perpetual Futures

The ongoing feud between the U.S. Commodity Futures Trading Commission (CFTC) and the Chicago Mercantile Exchange (CME) has reached a boiling point, with the two entities locked in a bitter dispute over the regulation of on-chain perpetual futures. The CFTC recently approved the listing of crypto perpetual futures, also known as perps, on the prediction markets platform Kalshi and cryptocurrency exchange Coinbase, sparking a lawsuit from the CME. The CME claims that the CFTC is mislabeling perps as futures, which are subject to different regulatory requirements. Perps are decentralized derivative contracts that allow users to speculate on the price of an asset with leverage and no expiration date, which the CME argues are harmful to its traditional futures products. The lawsuit has significant implications for the U.S. approach to the rapidly growing perps market, with non-U.S. perps volume reportedly reaching $60 trillion in volume last year. The CME's lawsuit argues that the CFTC's sudden embrace of perps did not consider the potential consequences and that the agency is misapplying the law. The regulator's decision to allow perps has been met with frustration from those on the side of the CFTC's reforming agenda, with some voicing outrage at the CME's attack on its own regulator. The CFTC's chairman, Mike Selig, has defended the agency's decision, stating that the CME's actions are wholly inappropriate. The dispute has also drawn in other industry players, with the Hyperliquid Policy Center (HPC) advocating for a lawful U.S. path to on-chain markets. The HPC's CEO, Jake Chervinsky, has criticized the CME's stance, arguing that it is typical of large incumbents trying to stifle innovation and competition. The CME's chairman, Terry Duffy, has countered that the CFTC has not followed the proper protocol and that perps are swaps, which are subject to different regulatory requirements. The outcome of the lawsuit is uncertain, but it is likely to have significant implications for the future of perps in the U.S. and the balance of power between regulators and industry players.